news
Top current pharmaceutical outsourcing trends
Most pharmaceutical companies are now outsourcing work to smaller firms, and here, European Pharmaceutical Review looks at current trends...
List view / Grid view
Big Data
news
Holistic approach to data management for pharmaceutical manufacturers
PharmaIntegrity makes it quick and easy to identify and trend cleanroom contamination problems before they occur...
news
Russian Institute for Drugs and Good Practices unveils new data guide
Improving data integrity is the aim of a new guide published by the Russian State Institute for Drugs and Good Practices in collaboration with consultancy PQE Group...
news
Public trust in use of Big Data for health science ‘is vital’: researchers
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
news
Pharmacovigilance of new drugs ‘should be more proactive’ in New Zealand
The pharmacovigilance of new drugs and drug formulations undertaken in New Zealand should be proactive, says a leading expert.
article
Non-mutagenic impurities: more guidance needed on safety-based limits
More guidance is needed on the appropriate control of non-mutagenic impurities during clinical development, explains Dave P Elder, JPAG Member and pharmaceutical industry consultant, in this audio interview.
news
The future of water is clear – MECO ushers in a more efficient and environmentally friendly future for water purification
Taking advantage of technology developed in recent years, MECO announces smartANALYTICS® as a means of connecting its water purification machines and systems with big data analytics and in house expertise...
news
Machine learning may reveal cause-effect relationships in protein dynamics data
A group of researchers is showing how artificial intelligence approaches can help identify cause-effect relationships within data...
article
Issue #2 2018 – Digital Version
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
whitepaper
Application Note: Applying QbD in Process and Impurity Control Strategy Development
Global regulatory authorities continue to push Quality-by-Design (QbD) on pharmaceutical groups and their supporting corporate informatics infrastructure...
news
Online tool provides 3-D view of human metabolic processes
An international team of researchers has developed a computational resource that provides a 3D view of genes, proteins and metabolites involved in human metabolism...
news
The bioprocess platform software eve® is now compatible with Applikon and Sartorius bioreactors
Bottmingen, The latest version of eve® can integrate with a wide range of third-party bioreactors and equipment from a number of different suppliers, e.g. Sartorius DCU, Applikon or Matlab...
news
£54 million funding to transform health through data science
Health Data Research UK is awarding £30 million funding to six sites across the UK to address challenging healthcare issues through the use of data science...
news
NIH partnership to improve clinical trials for Parkinson’s disease
The NIH is teaming with the government, biopharmaceutical, life science and non-profit organisations to overcome obstacles and increase success for advancing promising treatments for PD...
article
What’s next for big data?
The emergence of big data, technological innovations and advancements in scientific research is set to be transformative for the pharmaceutical industry, providing faster access to insights that can drive more informed decision making and accelerate drug development. Dr Chris Barber, CEO of Lhasa Limited, looks at what is next for…
